Pro Medicus Ltd
F:PMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pro Medicus Ltd
F:PMC
|
AU |
|
A
|
Abbvie Inc
SIX:ABBV
|
US |
|
Swiss Prime Site AG
F:SU1N
|
CH |
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
Wall St Price Targets
PMC Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PMC is 187.73 EUR with a low forecast of 135.3 EUR and a high forecast of 239.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PMC's stock price target?
Price Target
187.73
EUR
According to Wall Street analysts, the average 1-year price target for PMC is 187.73 EUR with a low forecast of 135.3 EUR and a high forecast of 239.56 EUR.
What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 22%.
What is the Gross Profit forecast for Pro Medicus Ltd?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 4 years is 22%.
What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 4 years is 22%.
What is the Pre-Tax Income forecast for Pro Medicus Ltd?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 48%. The projected CAGR for the next 3 years is 29%.
What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 4 years is 24%.
